• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

α1-抗胰蛋白酶缺乏症肝病。

Alpha-1-Antitrypsin Deficiency Liver Disease.

机构信息

Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, Saint Louis University School of Medicine, 1465 South Grand Boulevard, St Louis, MO 63104, USA.

Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, Saint Louis University School of Medicine, 1465 South Grand Boulevard, St Louis, MO 63104, USA; Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, 1465 South Grand Boulevard, St Louis, MO 63104, USA.

出版信息

Clin Liver Dis. 2018 Nov;22(4):643-655. doi: 10.1016/j.cld.2018.06.010. Epub 2018 Aug 22.

DOI:10.1016/j.cld.2018.06.010
PMID:30266154
Abstract

In homozygous ZZ alpha-1-antitrypsin (AAT) deficiency, the liver synthesizes large quantities of AAT mutant Z, which folds improperly during biogenesis and is retained within the hepatocytes and directed into intracellular proteolysis pathways. These intracellular polymers trigger an injury cascade, which can lead to liver injury. This is highly variable and not all patients develop liver disease. Although not fully described, there is likely a strong influence of genetic and environmental modifiers of the injury cascade and of the fibrotic response. With improved understanding of liver injury mechanisms, new strategies for treatment are now being explored.

摘要

在纯合子 ZZ 型α-1-抗胰蛋白酶(AAT)缺乏症中,肝脏合成大量突变型 Z 的 AAT,该蛋白在生物发生过程中折叠不正确,滞留在肝细胞内,并定向进入细胞内蛋白水解途径。这些细胞内聚合物触发损伤级联反应,从而导致肝损伤。这种情况具有高度变异性,并非所有患者都会发展为肝病。尽管尚未完全描述,但损伤级联反应和纤维化反应的遗传和环境修饰物可能具有很强的影响。随着对肝损伤机制的深入了解,目前正在探索新的治疗策略。

相似文献

1
Alpha-1-Antitrypsin Deficiency Liver Disease.α1-抗胰蛋白酶缺乏症肝病。
Clin Liver Dis. 2018 Nov;22(4):643-655. doi: 10.1016/j.cld.2018.06.010. Epub 2018 Aug 22.
2
Liver disease in alpha-1 antitrypsin deficiency: current understanding and future therapy.α-1 抗胰蛋白酶缺乏症相关肝病:当前认识与未来治疗。
COPD. 2013 Mar;10 Suppl 1:35-43. doi: 10.3109/15412555.2013.765839.
3
Alpha-1 Antitrypsin Deficiency Liver Disease.α-1 抗胰蛋白酶缺乏症肝病。
Clin Liver Dis. 2022 Aug;26(3):391-402. doi: 10.1016/j.cld.2022.03.004. Epub 2022 Jun 25.
4
Advances in alpha-1-antitrypsin deficiency liver disease.α-1抗胰蛋白酶缺乏性肝病的进展
Curr Gastroenterol Rep. 2014 Jan;16(1):367. doi: 10.1007/s11894-013-0367-8.
5
Alpha-1 antitrypsin and liver disease: mechanisms of injury and novel interventions.α-1抗胰蛋白酶与肝病:损伤机制及新干预措施
Expert Rev Gastroenterol Hepatol. 2015 Feb;9(2):261-8. doi: 10.1586/17474124.2014.943187. Epub 2014 Jul 28.
6
Pathophysiology of Alpha-1 Antitrypsin Deficiency Liver Disease.α-1抗胰蛋白酶缺乏性肝病的病理生理学
Methods Mol Biol. 2017;1639:1-8. doi: 10.1007/978-1-4939-7163-3_1.
7
Alpha-1 antitrypsin deficiency liver disease.α-1抗胰蛋白酶缺乏症肝病
Transl Gastroenterol Hepatol. 2021 Apr 5;6:23. doi: 10.21037/tgh.2020.02.23. eCollection 2021.
8
Alpha-1-antitrypsin deficiency: diagnosis, pathophysiology, and management.α-1抗胰蛋白酶缺乏症:诊断、病理生理学及管理
Curr Gastroenterol Rep. 2006 Feb;8(1):14-20. doi: 10.1007/s11894-006-0059-8.
9
Alpha-1-antitrypsin deficiency: Genetic variations, clinical manifestations and therapeutic interventions.α-1-抗胰蛋白酶缺乏症:遗传变异、临床表现和治疗干预。
Mutat Res Rev Mutat Res. 2017 Jul;773:14-25. doi: 10.1016/j.mrrev.2017.03.001. Epub 2017 Mar 18.
10
[Hepatic involvement in hereditary alpha-1-antitrypsin deficiency].[遗传性α1-抗胰蛋白酶缺乏症的肝脏受累情况]
Rev Mal Respir. 2014 Apr;31(4):357-64. doi: 10.1016/j.rmr.2013.10.651. Epub 2014 Mar 27.

引用本文的文献

1
N-glycan-dependent protein maturation and quality control in the ER.内质网中N-聚糖依赖性蛋白质成熟与质量控制
Nat Rev Mol Cell Biol. 2025 May 19. doi: 10.1038/s41580-025-00855-y.
2
Is It Time Alpha-1 Antitrypsin Deficiency Had a Specific Patient Reported Outcome Measure? A Review.α-1抗胰蛋白酶缺乏症是否到了拥有特定患者报告结局指标的时候?一项综述。
Patient Relat Outcome Meas. 2025 Jan 15;16:23-35. doi: 10.2147/PROM.S490849. eCollection 2025.
3
Alpha-1 Antitrypsin Inclusions Sequester GRP78 in a Bile Acid-Inducible Manner.α-1抗胰蛋白酶包涵体以胆汁酸诱导的方式隔离GRP78。
Liver Int. 2025 Jan;45(1):e16207. doi: 10.1111/liv.16207.
4
Alpha-1-antitrypsin-deficiency is associated with lower cardiovascular risk: an approach based on federated learning.α1-抗胰蛋白酶缺乏症与较低的心血管风险相关:基于联邦学习的方法。
Respir Res. 2024 Jan 18;25(1):38. doi: 10.1186/s12931-023-02607-y.
5
Neonatal cholestasis in children with Alpha-1-AT deficiency is a risk for earlier severe liver disease with male predominance.α1-抗胰蛋白酶缺乏症患儿的新生儿胆汁淤积症是导致更严重肝病的风险因素,且男性发病居多。
Hepatol Commun. 2023 Dec 7;7(12). doi: 10.1097/HC9.0000000000000345. eCollection 2023 Dec 1.
6
An Alpha-1 Antitrypsin Deficiency Screening Study in Patients with Chronic Obstructive Pulmonary Disease, Bronchiectasis, or Asthma in Turkey.土耳其慢性阻塞性肺疾病、支气管扩张或哮喘患者的α-1 抗胰蛋白酶缺乏症筛查研究。
Int J Chron Obstruct Pulmon Dis. 2023 Nov 28;18:2785-2794. doi: 10.2147/COPD.S425835. eCollection 2023.
7
Fecal and Circulating Biomarkers for the Non-Invasive Assessment of Intestinal Permeability.用于肠道通透性无创评估的粪便和循环生物标志物
Diagnostics (Basel). 2023 Jun 5;13(11):1976. doi: 10.3390/diagnostics13111976.
8
Nanomaterials for mRNA-based therapeutics: Challenges and opportunities.用于基于mRNA的治疗的纳米材料:挑战与机遇
Bioeng Transl Med. 2023 Jan 29;8(3):e10492. doi: 10.1002/btm2.10492. eCollection 2023 May.
9
The conformational landscape of a serpin N-terminal subdomain facilitates folding and in-cell quality control.丝氨酸蛋白酶抑制剂N端亚结构域的构象景观促进折叠和细胞内质量控制。
bioRxiv. 2023 Apr 26:2023.04.24.537978. doi: 10.1101/2023.04.24.537978.
10
Serum Protein Electrophoretic in Children.儿童血清蛋白电泳
Int J Pediatr. 2023 Mar 2;2023:7985231. doi: 10.1155/2023/7985231. eCollection 2023.